Anxiety Disorders, Borderline Personality Disorder, Depressive Disorder, Ptsd
Conditions
Brief summary
Implementation and evaluation of video consultation in psychiatric outpatient treatment. The study will focus on patients' experiences regarding the use of VC. The study will also examine important aspects of the telepsychiatric consultation such as therapeutic alliance, consultation content, psychopathology and satisfaction levels compared to face-to-face consultations.
Interventions
Case management cover therapy (psychotherapy/psychoeducation), medication adjustment, training in daily living skills (supportive), and direct consultations in crises.
Sponsors
Study design
Eligibility
Inclusion criteria
* age \> 18 years * Danish-speaking.
Exclusion criteria
*
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| The demand for video consultation (VC) in clinical practice. | One year | The demand for VC is evaluated by the percentage of included participants who chose to be in the VC group and the actual use of VC consultation sessions during the study period, including the number of missed appointments and the number of times VC sessions have been converted to telephone or in-person (IP) consultations. |
| Patients' therapeutic alliance, assessed by working alliance inventory- client version (WAI-C) | Two months. | Therapeutic alliance is evaluated with the mean change scores in the WAI-C questionnaire at baseline and posttreatment. Score ranging: from 12 to 84. Higher scores indicate a higher therapeutic alliance |
| Patients' satisfaction, assessed by client satisfaction questionnaire 8 (CSQ-8) | Two months. | Satisfaction is evaluated with the mean change scores in the CSQ-8 questionnaire at baseline and posttreatment. Score ranging: from 8 to 32. Higher scores indicate a higher satisfaction |
| Patients' Symptom level, assessed by Symptom Checklist -10 (SCL-10) | Two months. | Symptom level is evaluated with the mean change scores in the SCL-10 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Lower score indicates lower psychological distress |
| Patients' well-being, assessed by World Health Organisation- Five Well-Being Index (WHO-5) | Two months. | Well-being level is evaluated with the mean change scores in the WHO-5 questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. Higher scores indicate higher well-being |
| Patients' function, assessed by Sheehan Disability Scale (SDS) | Two months. | Functional impairment is evaluated with the mean change scores in the SDS questionnaire at baseline and posttreatment. Score ranging: from 0 to 30. lower scores indicate lower functional impairment |
| Patient recovery, assessed by INSPIRE | Two months. | Patient recovery is evaluated with the mean change scores in the INSPIRE questionnaire at baseline and posttreatment. Score ranging: from 0 to 100. A higher score indicates higher recovery |
| The implementation and integration of VC in clinical practice, as assessed by a checklist developed for the case managers (CM). | One year | The following properties are used to evaluate the implementation and integration properties: 1. type of technology patients use for VC sessions (Smartphone/tablet or personal computer/laptop) 2. patients' physical location during VC session (Home or outdoor) 3. the VC sessions confidentiality (Alone or with other persons) 4. duration of VC session 5. the content of the VC sessions (supportive, therapy, medication management, crisis/acute or mix content) Descriptive statistics will be applied to evaluate the implementation and integration properties. |
| Patients' experiences regarding the use of VC | Two months | Semistructured interviews have been conducted to evaluate participants' experience regarding the use of VC technology in clinical practice. |
Countries
Denmark